Compare Mahindra Manulife Mid Cap Fund vs Invesco India Mid Cap Fund
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 1.85 | 1.72 |
NAV | ₹33.78 | ₹178.78 |
Fund Started | 08 Jan 2018 | 15 Feb 2007 |
Fund Size | ₹4294.84 Cr | ₹10296.36 Cr |
Exit Load | Exit load of 1% if redeemed within 3 months. | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.85
1.72
NAV
₹33.78
₹178.78
Fund Started
08 Jan 2018
15 Feb 2007
Fund Size
₹4294.84 Cr
₹10296.36 Cr
Exit Load
Exit load of 1% if redeemed within 3 months.
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year | 6.27% | 10.28% |
3 Year | 24.23% | 26.47% |
5 Year | 22.77% | 22.31% |
1 Year
6.27%
10.28%
3 Year
24.23%
26.47%
5 Year
22.77%
22.31%
Equity | 98.23% | 97.50% |
Cash | 1.77% | 2.50% |
Equity
98.23%
97.50%
Cash
1.77%
2.50%
Top 10 Holdings |
|
|
Top 10 Holdings
Glenmark Pharmaceuticals Ltd. | 3.11% |
Indian Bank | 2.90% |
Max Financial Services Ltd. | 2.62% |
The Federal Bank Ltd. | 2.59% |
IDFC First Bank Ltd. | 2.54% |
Piramal Finance Ltd. | 2.49% |
AIA Engineering Ltd. | 2.48% |
UNO Minda Ltd. | 2.38% |
Indusind Bank Ltd. | 2.26% |
APL Apollo Tubes Ltd. | 2.24% |
The Federal Bank Ltd. | 5.79% |
AU Small Finance Bank Ltd. | 5.73% |
L&T Finance Ltd. | 5.17% |
Swiggy Ltd. | 5.14% |
Interglobe Aviation Ltd. | 4.00% |
Max Financial Services Ltd. | 3.93% |
BSE Ltd. | 3.88% |
Prestige Estates Projects Ltd. | 3.80% |
Global Health Ltd. | 3.70% |
Glenmark Pharmaceuticals Ltd. | 3.68% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 08 Jan 2018 | 15 Feb 2007 |
Description
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
Launch Date
08 Jan 2018
15 Feb 2007